GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $517,000 | +8.4% | 11,779 | +9.0% | 0.21% | +19.1% |
Q1 2022 | $477,000 | +16.9% | 10,809 | +16.7% | 0.18% | +17.1% |
Q4 2021 | $408,000 | +12.7% | 9,260 | -2.2% | 0.15% | +2.0% |
Q3 2021 | $362,000 | +3.4% | 9,464 | +7.7% | 0.15% | +4.9% |
Q2 2021 | $350,000 | +10.4% | 8,786 | -1.1% | 0.14% | +2.9% |
Q1 2021 | $317,000 | -3.1% | 8,886 | 0.0% | 0.14% | -5.5% |
Q4 2020 | $327,000 | -12.8% | 8,886 | -10.7% | 0.15% | -22.8% |
Q3 2020 | $375,000 | -7.6% | 9,953 | 0.0% | 0.19% | -19.2% |
Q2 2020 | $406,000 | +19.4% | 9,953 | +10.9% | 0.23% | -17.6% |
Q1 2020 | $340,000 | – | 8,978 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |